CSIMarket
 


Ocata Therapeutics, Inc.  (ACTC)
Other Ticker:  
 


Ocata Therapeutics's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



ACTC Net Cash Flow Margin (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Revenue Change 113.47 % -0 % 0 % 0.01 % -0 %
Seq. Revenue Change 113.47 % 0 % -0.01 % 0.01 % -0.01 %
Revenue In Millions $0.08 $0.04 $0.04 $0.04 $0.04
Net Cash Flow Margin - - -2259.48 % -8583.83 % -
Net Cash Flow Margin Total Ranking # 178 # 12 # # # 28
Net Cash Flow In Millions $0.29 $28.32 $-0.89 $-3.39 $3.75
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2015 Net Cash Flow Margin
Company's Net Cash Flow Margin decreased in III. Quarter to 339.41 %, below company's average Net Cash Flow Margin.

Observing third quarter 2015 results within Biotechnology & Pharmaceuticals industry 15 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from 12 to 178.

ACTC's Net Cash Flow Margin third quarter 2015 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 58
Overall # 144

Net Cash Flow Margin Statistics
High Average Low
71751.73 % 14964.97 % 144.7 %
(Jun 30 2015)   (Jun 30 2014)




Other Net Cash Flow Margin Profitability Ratios
ACTC's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
ACTC's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for ACTC's Competitors
Net Cash Flow Margin Profit Margin for Ocata Therapeutics's Suppliers
Net Cash Flow Margin Profit Margin for ACTC's Customers

You may also want to know
ACTC's Annual Growth Rates ACTC's Profitability Ratios ACTC's Asset Turnover Ratio ACTC's Dividend Growth
ACTC's Roe ACTC's Valuation Ratios ACTC's Financial Strength Ratios ACTC's Net Cash Flow Growth
ACTC's Roa ACTC's Inventory Turnover Ratio ACTC's Growth Rates ACTC's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2015, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginSep 30 2015 MRQ Net Cash FlowSep 30 2015 MRQ Revenue
Applied Genetic Technologies Corporation  913.70 %$ 101.073 $ 11.062 
Agenus Inc  868.47 %$ 59.474 $ 6.848 
Exelixis Inc   849.33 %$ 83.693 $ 9.854 
Moderna Inc   733.75 %$ 0.587 $ 0.080 
Sorrento Therapeutics Inc   668.00 %$ 7.368 $ 1.103 
Seagen Inc   636.43 %$ 535.061 $ 84.072 
Cyclo Therapeutics Inc   560.74 %$ 1.316 $ 0.235 
United Bancshares Inc  518.83 %$ 4.513 $ 0.870 
Ocata Therapeutics, Inc.  339.41 %$ 0.286 $ 0.084 
Sangamo Therapeutics Inc   274.47 %$ 23.519 $ 8.569 
Acceleron Pharma inc  127.12 %$ 5.282 $ 4.155 
Biogen Inc   113.64 %$ 3,156.852 $ 2,777.859 
Adma Biologics Inc   73.20 %$ 1.356 $ 1.852 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com